Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 4:16 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 2,510 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Health Behavior
Interventions: peer counseling, Feedback report; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Tirasemtiv, Placebo tablets; Drug
Lead sponsor: Cytokinetics; Industry
Eligibility: 18 Years and older
Enrollment: 744 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 49
States / cities: Phoenix, Arizona • La Jolla, California • Los Angeles, California + 42 more

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Non-Hodgkins Lymphoma, Sarcoma, Neuroblastoma
Interventions: Food Safety Guidelines, Neutropenic Diet; Other
Lead sponsor: Indiana University; Other
Eligibility: 1 Year to 30 Years
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2017
U.S. locations: 6
States / cities: San Diego, California • Indianapolis, Indiana • Brooklyn, New York + 2 more

Conditions: Group B Streptococcus
Interventions: GBS culture and real time PCR; Other
Lead sponsor: MemorialCare Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 342 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Malignant Neoplasms of Urinary Tract, Bladder Cancer
Interventions: Rocuronium, Sugammadex, Neostigmine, Glycopyrrolate; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Poor Glycemic Control
Interventions: Metformin, Glargine insulin, Glulisine; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Anesthesia
Interventions: MTPI, Classic Induction; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Opioid-use Disorder
Interventions: TM buprenorphine, SUBLOCADE; Drug
Lead sponsor: Indivior Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Berlin, New Jersey

Conditions: Pregnancy
Interventions: AIM 4 Teen Moms; Behavioral
Lead sponsor: Mathematica Policy Research, Inc.; Other
Eligibility: 15 Years to 19 Years · Female only
Enrollment: 954 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 4
States / cities: Los Angeles, California • Mission Hills, California • Pacoima, California

Conditions: Duchenne Muscular Dystrophy
Interventions: Not listed
Lead sponsor: Skulpt, Inc.; Industry
Eligibility: Up to 18 Years · Male only
Enrollment: 327 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 5
States / cities: Aurora, Colorado • Boston, Massachusetts • St Louis, Missouri + 1 more

Conditions: Acute Lung Injury
Interventions: Diuresis (furosemide) part I, Fluid Bolus (crystalloid or albumin), Vasopressors (Norepinephrine, Vasopressin, Phenylephrine, Epinephrine), Dobutamine, Concentrate all drips and nutrition, Diuresis (furosemide) part II, Dialysis; Drug · Other · Procedure
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 3
States / cities: Clackamas, Oregon • Portland, Oregon

Conditions: Tonsillectomy
Interventions: Dexmedetomidine, Placebo; Drug · Other
Lead sponsor: Peter Davis; Other
Eligibility: 4 Years to 10 Years
Enrollment: 418 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania

Conditions: Depression, Depression Severe, Depression Acute, Depression and Suicide, Suicidal Ideation
Interventions: Ketamine, Sodium Chloride 0.9%; Drug
Lead sponsor: MercyOne Des Moines Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Des Moines, Iowa

Conditions: Healthy Volunteers
Interventions: IW-3300, Placebo; Drug
Lead sponsor: Ironwood Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Hepatic Impairment
Interventions: WCK 2349; Drug
Lead sponsor: Wockhardt; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Acute Ischemic Stroke
Interventions: Argatroban, Eptifibatide, Placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 514 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 61
States / cities: Birmingham, Alabama • Fullerton, California • La Jolla, California + 47 more

Conditions: Diabetes, Diabetic Macular Edema, Diabetic Retinopathy
Interventions: OCT imaging; Device
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years and older
Enrollment: 385 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 4
States / cities: Boston, Massachusetts • Wellfleet, Massachusetts • Syracuse, New York + 1 more

Conditions: Hepatic Impairment
Interventions: Glasdegib 100 mg single oral dose; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Miami, Florida • Orlando, Florida

Conditions: Suicide, Suicidal Ideation, Suicidal Impulses, Suicidal Intention, Suicidal and Self-Injurious Behavior, Suicidal Depression
Interventions: Neuronetics NeuroStar XPLOR magnetic stimulator - Active, Neuronetics NeuroStar XPLOR magnetic stimulator - Sham; Device
Lead sponsor: Eisenhower Army Medical Center; Federal
Eligibility: 18 Years to 60 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Febrile Infection, Anthrax
Interventions: TaqMan Bacillus anthracis Detection Kit; Device
Lead sponsor: MRI Global; Industry
Eligibility: 2 Years to 89 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 3
States / cities: Tarpon Springs, Florida • Fall River, Massachusetts • Franklin, Massachusetts

Conditions: Obstructive Sleep Apnea, Comorbid Insomnia and Sleep Apnea, Insomnia
Interventions: Digital Cognitive Behavioral Therapy (CBT-i)-COAST; Device
Lead sponsor: Thomas Kaffenberger; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Testing Effect of Intervention
Interventions: HCV RNA Rapid testing; Diagnostic Test
Lead sponsor: University of Washington; Other
Eligibility: 22 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Major Depressive Disorder
Interventions: NeuroStar TMS Therapy® System, NeuroStar XPLOR®; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 12 Years to 18 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Aging, Hearing Loss
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

Nutrition and Physical Activity Counseling for Nontraditional College Students

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor

Investigation of Sugammadex in Outpatient Urological Procedures

Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients

Intubation Conditions Achieved With Rapid Co-administration of Rocuronium and Propofol Versus Classical Induction

SUBLOCADE Rapid Initiation Study

Evaluation of the Efficacy of the AIM (Adult Identity Mentoring) 4 Teen Moms Program

A Device for Rapid, Painless, Bedside Muscle Evaluation of Children

Hemodynamics and Extravascular Lung Water in Acute Lung Injury

Dexmedetomidine as a Rapid Bolus in Children for Emergence Agitation

Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department

A Study of Single Ascending Doses of IW-3300 in Healthy Volunteers

Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment

Multi-arm Optimization of Stroke Thrombolysis

OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits

A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib

TMS for Suicidal Crisis in Active Duty SMs

Febrile Whole Blood Specimen Collection and Testing

Does the Timing of Insomnia Therapy (CBT-i) Impact the Usage and Compliance of Upper Airway Stimulation (UAS) Treatment of Obstructive Sleep Apnea (OSA)

One-step HCV RNA Testing Among SSP Participants (HOT Study)

Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression

Working Memory Changes With Aging and Hearing Loss